Creating diverse pool of trained scientists to address Alzheimer's research needs

Roberta Diaz Brinton, PhD, an internationally recognized expert on Alzheimer's disease and inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, has received a five-year, $1.8 million grant from the National Institutes of Health Institute on Aging.

With the funding, Dr. Brinton will develop a unique training program to cultivate a diverse pool of highly trained scientists from diverse fields who can effectively address the nation's Alzheimer's research needs.

"Curing Alzheimer's disease requires a multidisciplinary approach. We have the team and the strategy to build an innovative, expertise-diverse team to address this challenge," Dr. Brinton said. "Through this NIA training grant, we have the opportunity to innovate our national scientific and clinical workforce to develop therapeutics to address the epidemic of Alzheimer's disease."

To achieve that goal, Dr. Brinton and colleagues have designed an innovative, collaborative training program that is patient-inspired and data driven: the University of Arizona Translational Research on Alzheimer's Disease and AD Related Dementias program, or AZ-TRADD.

"Our goal," Dr. Brinton noted, "is to train the next generation of Alzheimer's researchers in 21st century team science that spans translational, clinical and big data science. Our stellar team of University of Arizona translational faculty and community partners is uniquely qualified to support and foster AZ-TRADD. Importantly, the UA's diverse, passionate and exceptional graduate and medical students are poised to be at the vanguard of innovators in developing cures for Alzheimer's."

"The innovative translational research at the University of Arizona into extending the cognitive health span to match our life spans is a strategic priority for the university and we are all thrilled by the incredible work that Dr. Brinton and her team are doing to understand Alzheimer' disease," said UA President Robert C. Robbins, MD. "I am confident that Dr. Brinton's team of world-class translational Alzheimer's researchers will develop the next generation of leaders in the field and, in turn, develop treatments and someday possible cures for this devastating disease that affects so many people across the globe."

Based at the UAHS Center for Innovation in Brain Science and the UAHS Clinical Translational Sciences Program, led by Jorge Gomez, MD, PhD, the AZ-TRADD training program will recruit predoctoral PhD, MD and PhD/MD students from across multiple disciplines to serve as fellows.

"Our program is designed to develop innovative translational researchers who embrace the complexity of Alzheimer's by providing them the best mentors and tools to cure this devastating disease," Dr. Brinton said.

To achieve the program's goal, Dr. Brinton has an "all brains on deck" approach. She is joined in this endeavor by UAHS Center for Innovation for Brain Science colleagues: Kathy Rodgers, PhD; Lalitha Madhaven, MD, PhD; Fei Yin, PhD; May Khanna, PhD; Kevin Gaffney, PhD; Rui Chang, PhD; Alex Thome, PhD; and 16 core faculty mentors across the University of Arizona, including UA McKnight Brain Institute members Carol Barnes, PhD, director and Regents' Professor, Lee Ryan, PhD, and Meredith Hay, PhD; Anita Koshy, MD; and UA Data Science Institute Director Nirav Merchant.

Through a diverse team of UA faculty "accelerators," AZ-TRADD fellows will receive in-depth training from UA experts in topics ranging from immunology to machine learning and therapeutic development. In addition, the program's community partners -- the Alzheimer's Association Desert Southwest Chapter and the Critical Path Institute -- will be key contributors.

In its inaugural year, the AZ-TRADD program will recruit six fellows.

The UA is one of three institutions in the United States and the first in the West to receive an NIA grant to develop training programs to advance translational research training for Alzheimer's disease and related dementias.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Anxiety and negative emotions reduced by brain circuit that consciously slows breathing